Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 29 Dec 2022 | |
Digestive System Disorders | Discovery | - | 29 Dec 2022 | |
Eye Diseases | Discovery | - | 29 Dec 2022 | |
Immune System Diseases | Discovery | - | 29 Dec 2022 | |
Infectious Diseases | Discovery | - | 29 Dec 2022 | |
Metabolic Diseases | Discovery | - | 29 Dec 2022 | |
Mouth Diseases | Discovery | - | 29 Dec 2022 | |
Neoplasms | Discovery | - | 29 Dec 2022 | |
Neurodegenerative Diseases | Discovery | - | 29 Dec 2022 | |
Other Diseases | Discovery | - | 29 Dec 2022 |